Mazzoni E, Frontini F, Rotondo JCharles, Zanotta N, Fioravanti A, Minelli F, Torreggiani E, Campisciano G, Marcuzzi A, Guerra G, Tommasini A, Touzé A, Martini F, Tognon M, Comar M. Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children. J Cell Physiol 2019;234(4):3170-3179.

Bernardi S, Marcuzzi A, Piscianz E, Tommasini A, Fabris B. The Complex Interplay between Lipids, Immune System and Interleukins in Cardio-Metabolic Diseases. Int J Mol Sci 2018;19(12)

Zanotta N, Campisciano G, Scrimin F, Blendi U, Marcuzzi A, Vincenti E, Crovella S, Comar M. Cytokine profiles of women with vulvodynia: Identification of a panel of pro-inflammatory molecular targets. Eur J Obstet Gynecol Reprod Biol 2018;226:66-70.

Marcuzzi A, Loganes C, Valencic E, Piscianz E, Monasta L, Bilel S, Bortul R, Celeghini C, Zweyer M, Tommasini A. Neuronal Dysfunction Associated with Cholesterol Deregulation. Int J Mol Sci 2018;19(5)

Marcuzzi A, Loganes C, Celeghini C, Kleiner G. Repositioning of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into Practice. Curr Med Chem 2018;25(24):2783-2796.

Loganes C, Lega S, Bramuzzo M, Brumatti LVecchi, Piscianz E, Valencic E, Tommasini A, Marcuzzi A. Curcumin Anti-Apoptotic Action in a Model of Intestinal Epithelial Inflammatory Damage. Nutrients 2017;9(6)

Marcuzzi A, Piscianz E, Zweyer M, Bortul R, Loganes C, Girardelli M, Baj G, Monasta L, Celeghini C. Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology. Int J Mol Sci 2016;17(3):365.

Marcuzzi A, Vozzi D, Girardelli M, Tricarico PMaura, Knowles A, Crovella S, Vuch J, Tommasini A, Piscianz E, Bianco AMonica. Putative modifier genes in mevalonate kinase deficiency. Mol Med Rep 2016;13(4):3181-9.

Tricarico PMaura, Girardelli M, Kleiner G, Knowles A, Valencic E, Crovella S, Marcuzzi A. Alendronate, a double-edged sword acting in the mevalonate pathway. Mol Med Rep 2015;12(3):4238-42.

Lougaris V, Faletra F, Lanzi G, Vozzi D, Marcuzzi A, Valencic E, Piscianz E, Bianco AM, Girardelli M, Baronio M, Loganes C, Fasth A, Salvini F, Trizzino A, Moratto D, Facchetti F, Giliani S, Plebani A, Tommasini A. Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype. Clin Immunol 2015;159(1):33-6.

Tricarico PMaura, Piscianz E, Monasta L, Kleiner G, Crovella S, Marcuzzi A. Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency. Apoptosis 2015;20(8):1048-55.

Kleiner G, Zanin V, Monasta L, Crovella S, Caruso L, Milani D, Marcuzzi A. Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1?, interleukin-2 and interleukin-17. Exp Ther Med 2015;9(6):2047-2052.

Marcuzzi A, Piscianz E, Valencic E, Monasta L, Brumatti LVecchi, Tommasini A. To Extinguish the Fire from Outside the Cell or to Shutdown the Gas Valve Inside? Novel Trends in Anti-Inflammatory Therapies. Int J Mol Sci 2015;16(9):21277-93.

Bianco AMonica, Faletra F, Vozzi D, Girardelli M, Knowles A, Tommasini A, Zauli G, Marcuzzi A. Two?gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results. Mol Med Rep 2015;12(4):6128-32.

Tricarico PMaura, Kleiner G, Valencic E, Campisciano G, Girardelli M, Crovella S, Knowles A, Marcuzzi A. Block of the mevalonate pathway triggers oxidative and inflammatory molecular mechanisms modulated by exogenous isoprenoid compounds. Int J Mol Sci 2014;15(4):6843-56.

Brumatti LVecchi, Marcuzzi A, Tricarico PMaura, Zanin V, Girardelli M, Bianco AMonica. Curcumin and inflammatory bowel disease: potential and limits of innovative treatments. Molecules 2014;19(12):21127-53.

Bianco AMonica, Girardelli M, Vozzi D, Crovella S, Kleiner G, Marcuzzi A. Mevalonate kinase deficiency and IBD: shared genetic background. Gut 2014;63(8):1367-8.

Bianco AMonica, Zanin V, Monasta L, Martelossi S, Marcuzzi A, Crovella S. Family history in early-onset inflammatory bowel disease. J Gastroenterol 2013;48(1):144.

Bianco AMonica, Zanin V, Marcuzzi A, Crovella S. Clarification of the pleiotropic effects of statins on mevalonate pathway and the feedback regulation of isoprenoids requires more comprehensive investigation. Cell Biochem Funct 2012;30(2):176.

Vuch J, Marcuzzi A, Zanin V, Crovella S. Comments to the editor concerning the paper entitled "Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways" Shiekh Tanveer Ahmad et al. Toxicology 2012;293(1-3):123-4.

Bianco AMonica, Zanin V, Girardelli M, Magnolato A, Martelossi S, Martellossi S, Tommasini A, Marcuzzi A, Crovella S. A common genetic background could explain early-onset Crohn's disease. Med Hypotheses 2012;78(4):520-2.

Zanin V, Marcuzzi A, Piscianz E, Vuch J, Bianco AMonica, Monasta L, Decorti G, Crovella S. The effect of clodronate on a mevalonate kinase deficiency cellular model. Inflamm Res 2012;61(12):1363-7.

Marcuzzi A, Girardelli M, Bianco AMonica, Martelossi S, Magnolato A, Tommasini A, Crovella S. Inflammation profile of four early onset Crohn patients. Gene 2012;493(2):282-5.

Marcuzzi A, Zanin V, Piscianz E, Tricarico PMaura, Vuch J, Girardelli M, Monasta L, Bianco AMonica, Crovella S. Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line. Int J Dev Neurosci 2012;30(6):451-6.

Marcuzzi A, Crovella S, Monasta L, Brumatti LVecchi, Gattorno M, Frenkel J. Mevalonate kinase deficiency: disclosing the role of mevalonate pathway modulation in inflammation. Curr Pharm Des 2012;18(35):5746-52.

Tricarico PMaura, Marcuzzi A, Zanin V, Kleiner G, Bianco AMonica, Crovella S. Serum amyloid A and cholesterol: a pivotal role on inflammation. Amyloid 2012;19(3):163-4; author reply 165-6.

Zanin V, Delbue S, Marcuzzi A, Tavazzi E, Del Savio R, Crovella S, Marchioni E, Ferrante P, Comar M. Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders. J Neurovirol 2012;18(5):416-22.

Marcuzzi A, Secchiero P, Crovella S, Zauli G. TRAIL administration down-modulated the acute systemic inflammatory response induced in a mouse model by muramyldipeptide or lipopolysaccharide. Cytokine 2012;60(1):43-6.

Marcuzzi A, Zanin V, Crovella S, Pontillo A. Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011). Oral Oncol 2011;47(5):436-7; author reply 438.

Marcuzzi A, De Leo L, Decorti G, Crovella S, Tommasini A, Pontillo A. The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency. Pediatr Res 2011;70(1):78-82.

Marcuzzi A, Crovella S, Pontillo A. Geraniol rescues inflammation in cellular and animal models of mevalonate kinase deficiency. In Vivo 2011;25(1):87-92.

Marcuzzi A, Zanin V, Vuch J, Pontillo A, Crovella S. Letter to the editor: acute effects of intravenous administration of pamidronate in patients with osteoporosis. J Korean Med Sci 2011;26(6):848-9; author reply 850.

Marcuzzi A, Decorti G, Pontillo A, Ventura A, Tommasini A. Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency. Inflamm Res 2010;59(5):335-8.

Marcuzzi A, Tommasini A, Crovella S, Pontillo A. Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes. Int Immunopharmacol 2010;10(6):639-42.

De Leo L, Marcuzzi A, Decorti G, Tommasini A, Crovella S, Pontillo A. Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches. Pharmacol Res 2010;61(6):506-10.